@ARTICLE{
author={Giles Francis J,...,Boskovic Darinka V,...,(broj koautora 17)},
year={2009},
title={Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapse},
journal={BLOOD},
volume={114},
number={19},
pages={4027-4033},
document_type={Article},
} 

@ARTICLE{
author={Norbert N,Pigneux A,Boskovic Darinka V,Giles Francis J},
year={2008},
title={A Double Blind Placebo-Controlled Randomized Phase Iii Study Of High Dose Continuous Infusion Cytosine Arabinoside (Arac) With Or Without Vnp40101m (Cloretazine (R)) In Patients With First Relapse Of Acute Myeloid Leukemia (Aml)},
journal={HAEMATOLOGICA-THE HEMATOLOGY JOURNAL},
volume={93},
number={},
pages={0035-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Giles Francis J,Stock Wendy,Vey Norbert,Sciter Karen,DeAngelo Daniel J,Boskovic Darinka V,Stuart Robert K,Johnson Bonny,Cahill Ann L,O'Brien Susan},
year={2006},
title={A double blind placebo-controlled randomized phase III study of high dose continuous infusion cytosine arabinoside (araC) with or without cloretazine (R) in patients with first relapse of acute myeloid leukemia (AML).},
journal={BLOOD},
volume={108},
number={11},
pages={557A-557A},
document_type={Meeting Abstract},
}